Kei Ikeda (K Ikeda)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 28

Top Topics

Rheumatoid Arthritis

Toxoplasma Gondii

Interstitial Lung Disease

Top Venues

Annals of the rheumatic diseases

Modern rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, Manami Kato, Fumiyoshi Takizawa, Tomoaki Ida, Junya Suzuki, Yosuke Toda, Kazusa Miyachi, Arifumi Iwata, Shunsuke Furuta, Kei Ikeda, Hiroshi Nakajima
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD open 10 (1) (2024)
Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, Manami Kato, Fumiyoshi Takizawa, Tomoaki Ida, Junya Suzuki, Yosuke Toda, Kazusa Miyachi, Arifumi Iwata, Shunsuke Furuta, Kei Ikeda, Hiroshi Nakajima
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD open 10 (1) (2024)
Shotaro Kojima, Taro Iwamoto, Yoshihisa Kobayashi, Manami Kato, Fumiyoshi Takizawa, Tomoaki Ida, Junya Suzuki, Yosuke Toda, Kazusa Miyachi, Arifumi Iwata, Shunsuke Furuta, Kei Ikeda, Hiroshi Nakajima
Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. RMD open 10 (1) (2024)
Norihiro Mimura, Taro Iwamoto, Shunsuke Furuta, Kei Ikeda, Yoshihisa Kobayashi, Takayuki Nakamura, Aiko Saku, Shin-Ichiro Kagami, Ayako Matsuki, Kentaro Takahashi, Takeshi Umibe, Daiki Nakagomi, Yoshie Sanayama, Toyohiko Sugimoto, Masashi Fukuta, Masaki Hiraguri, Hirotoshi Kawashima, Koichi Hirose, Hiroaki Takatori, Kenichi Suehiro, Shigekazu Takahashi, Tomohiro Tamachi, Manami Kato, Fumiyoshi Takizawa, Yuuya Kawarai, Shigeo Hagiwara, Junichi Nakamura, Seiji Ohtori, Hiroshi Nakajima
Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Kazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, Takao Sugiyama, Shin-Ichiro Kagami, Daiki Nakagomi, Taro Iwamoto, Kei Ikeda, Hiroshi Nakajima
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Yuko Kaneko, Hideto Kameda, Kei Ikeda, Katsuhisa Yamashita, Ryoto Ozaki, Yoshiya Tanaka
Treatment pattern and changes in oral glucocorticoid dose after tocilizumab treatment in patients with adult Still's disease: An analysis of a Japanese claims database. International journal of rheumatic diseases (2023)
Norihiro Mimura, Taro Iwamoto, Shunsuke Furuta, Kei Ikeda, Yoshihisa Kobayashi, Takayuki Nakamura, Aiko Saku, Shin-Ichiro Kagami, Ayako Matsuki, Kentaro Takahashi, Takeshi Umibe, Daiki Nakagomi, Yoshie Sanayama, Toyohiko Sugimoto, Masashi Fukuta, Masaki Hiraguri, Hirotoshi Kawashima, Koichi Hirose, Hiroaki Takatori, Kenichi Suehiro, Shigekazu Takahashi, Tomohiro Tamachi, Manami Kato, Fumiyoshi Takizawa, Yuuya Kawarai, Shigeo Hagiwara, Junichi Nakamura, Seiji Ohtori, Hiroshi Nakajima
Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study. RMD open 9 (1) (2023)
Kazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, Takao Sugiyama, Shin-Ichiro Kagami, Daiki Nakagomi, Taro Iwamoto, Kei Ikeda, Hiroshi Nakajima
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Shunsuke Furuta, Daiki Nakagomi, Yoshihisa Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin-Ichiro Kagami, Yosuke Inaba, Hideki Hanaoka, Kei Ikeda, Hiroshi Nakajima, null null
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study. Annals of the rheumatic diseases (2023)
Kazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, Takao Sugiyama, Shin-Ichiro Kagami, Daiki Nakagomi, Taro Iwamoto, Kei Ikeda, Hiroshi Nakajima
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD open 9 (1) (2023)
Kazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, Takao Sugiyama, Shin-Ichiro Kagami, Daiki Nakagomi, Taro Iwamoto, Kei Ikeda, Hiroshi Nakajima
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD open 9 (1) (2023)
Tomoaki Ida, Shunsuke Furuta, Asuka Takayama, Jun Tamura, Yuki Hayashi, Kazuya Abe, Syunjiro Kurihara, Junichi Ishikawa, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD open 9 (1) (2023)
Norihiro Mimura, Taro Iwamoto, Shunsuke Furuta, Kei Ikeda, Yoshihisa Kobayashi, Takayuki Nakamura, Aiko Saku, Shin-Ichiro Kagami, Ayako Matsuki, Kentaro Takahashi, Takeshi Umibe, Daiki Nakagomi, Yoshie Sanayama, Toyohiko Sugimoto, Masashi Fukuta, Masaki Hiraguri, Hirotoshi Kawashima, Koichi Hirose, Hiroaki Takatori, Kenichi Suehiro, Shigekazu Takahashi, Tomohiro Tamachi, Manami Kato, Fumiyoshi Takizawa, Yuuya Kawarai, Shigeo Hagiwara, Junichi Nakamura, Seiji Ohtori, Hiroshi Nakajima
Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study. RMD open 9 (1) (2023)
Junya Suzuki, Shunsuke Furuta, Takahiro Sugiyama, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima
Antiphospholipid Antibody Positivity and the Thrombotic Risk in Japanese Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Modern rheumatology (2022)
Katsuhiko Takabayashi, Fumihiko Ando, Kei Ikeda, Hiroshi Nakajima, Hideki Hanaoka, Takahiro Suzuki
Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort study. Modern rheumatology (2022)
Yoshiya Tanaka, Claire Barrett, Yuji Hirano, Kei Ikeda, Kathy Paizis, Azusa Sameshima, Irina Mountian, Priscilla Ch Wong
Management of chronic rheumatic diseases in women 18-45 years of age in Asia Pacific: insights from patient and clinician surveys. Rheumatology international (2022)
Katsuhiko Takabayashi, Fumihiko Ando, Kei Ikeda, Shinsuke Fujita, Hiroshi Nakajima, Hideki Hanaoka, Takahiro Suzuki
Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study. Modern rheumatology 32 (5) (2022)
Jeanette Trickey, Ilfita Sahbudin, Mads Ammitzbøll Danielsen, Irene Azzolin, Carina Borst, Alessandra Bortoluzzi, George A W Bruyn, Philippe Carron, Coziana Ciurtin, Georgios Filippou, Jacek Fliciński, Daniela Fodor, Hélène Gouze, Marwin Gutierrez, Hilde Berner Hammer, Ellen-Margrethe Hauge, Annamaria Iagnocco, Kei Ikeda, Rositsa Valerieva Karalilova, Helen Isobel Keen, Marion Kortekaas, Giuliana La Paglia, Gustavo Leon, Peter Mandl, Mihaela Maruseac, Marcin Milchert, Mohamed Atia Mortada, Esperanza Naredo, Sarah Ohrndorf, Carlos Javier Pineda-Villaseñor, Mads Nyhuus Bendix Rasch, Cristina Reatégui-Sokolova, Garifallia Sakellariou, Teodora Serban, Cesar A Sifuentes-Cantú, Maria S Stoenoiu, Takeshi Suzuki, Lene Terslev, Ilaria Tinazzi, Florentin Ananu Vreju, Ruth Wittoek, Maria Antonietta D'Agostino, Andrew Filer
Very low prevalence of ultrasound-detected tenosynovial abnormalities in healthy subjects throughout the age range: OMERACT ultrasound minimal disease study. Annals of the rheumatic diseases (2021)
Hiroki Furuya, Mikio Nakajima, Kei Ikeda, Kaito Nakamura, Hiroyuki Ohbe, Shotaro Aso, Ryosuke Kumazawa, Taro Iwamoto, Arifumi Iwata, Shunsuke Furuta, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Hiroshi Nakajima
Prognosis and treatment of myositis-associated severe interstitial lung disease: A descriptive study using a nation-wide inpatient database in Japan. Arthritis care & research (2021)
Manami Kato, Kei Ikeda, Takahiro Sugiyama, Shigeru Tanaka, Kazuma Iida, Kensuke Suga, Nozomi Nishimura, Norihiro Mimura, Tadamichi Kasuya, Takashi Kumagai, Hiroki Furuya, Taro Iwamoto, Arifumi Iwata, Shunsuke Furuta, Akira Suto, Kotaro Suzuki, Eiryo Kawakami, Hiroshi Nakajima
Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis. PloS one 16 (5) (2021)
Takahisa Gono, Kenichi Masui, Naoshi Nishina, Yasushi Kawaguchi, Atsushi Kawakami, Kei Ikeda, Yohei Kirino, Yumiko Sugiyama, Yoshinori Tanino, Takahiro Nunokawa, Yuko Kaneko, Shinji Sato, Katsuaki Asakawa, Taro Ukichi, Shinjiro Kaieda, Taio Naniwa, Yutaka Okano, Masataka Kuwana, null null
Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease. Arthritis & rheumatology (Hoboken, N.J.) 73 (4) (2021)
H Furuya, Kei Ikeda, K Iida, K Suzuki, S Furuta, T Tamachi, K Suzuki, G Miura, M Hiraguri, R Hase, K Hikosaka, K Norose, H Nakajima
Disseminated toxoplasmosis with atypical symptoms which developed with exacerbation of systemic lupus erythematosus. Lupus 28 (1) (2018)
Yuko Kaneko, Hideto Kameda, Kei Ikeda, Tomonori Ishii, Kosaku Murakami, Hyota Takamatsu, Yoshiya Tanaka, Takayuki Abe, Tsutomu Takeuchi
Response to: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee. Annals of the rheumatic diseases 78 (12) (2018)
Yuko Kaneko, Hideto Kameda, Kei Ikeda, Tomonoti Ishii, Kosaku Murakami, Hyota Takamatsu, Yoshiya Tanaka, Takayuki Abe, Tsutomu Takeuchi
Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. Annals of the rheumatic diseases 77 (12) (2018)
Yoshihisa Kobayashi, Kei Ikeda, Takayuki Nakamura, Mieko Yamagata, Takuya Nakazawa, Shigeru Tanaka, Shunsuke Furuta, Takeshi Umibe, Hiroshi Nakajima
Severity and Diurnal Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid Arthritis. PloS one 11 (11) (2016)